Investing.comQwen · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 22:00:38·⟳ 抓取 22:01:44 +1m06s·⚡ 决策 08-31 22:02:36 +52s·56.9 天前
康宝莱重申2026年三季度及全年业绩指引，无任何新增信息
本次事件是Herbalife对2026年8月5日已披露指引的原文重申，所有数字区间（Q3净销售增长0.5%-4.5%、调整后EBITDA $160-180M；全年净销售增长2.5%-5.5%、调整后EBITDA $670-690M）和汇率假设均未发生任何变化。CFO表态仅为'outlook firmly on track'。不存在新增事实、方向性变化或预期差，无法形成任何方向的交易edge。
📄 原文Investing.com↗ 原文
Herbalife reaffirms third quarter and full-year 2026 guidance
Wall Street slips at the open as oil prices surge on sharp U.S.-Iran escalation LOS ANGELES - Herbalife Ltd. (NYSE:HLF)…
不做 Herbalife Ltd.（HLF.US）
本次事件为2026-08-05已披露指引的原文重申，所有数字与假设零变更，无新增事实、无方向性变化、无预期差，不构成任何方向的可交易催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Herbalife于8月31日发布新闻稿重申8月5日已给出的Q3和FY2026指引，所有数字与假设完全一致，无任何上调、下调或新增披露。重申指引本身不改变市场对公司的预期，不构成新增利多或利空。来源为Investing.com AI生成稿件，无一手增量信息。结论：无可交易催化，AVOID。
🔎 新鲜度:最早出现 2026-08-31 · 扩散 low · price-in 风险 high ↗
先例如何影响了这次决策
对本次决策的影响:先例研究不适用于本事件：重申指引无新增信息，不存在可类比的事件催化机制
方向:无适用先例——重申已有指引不构成独立事件类型，历史上无对应的价格反应模式
涨幅量级:不适用
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 84 ms
{"result": "search_processed_events:agent query=`herbalife reaffirms guidance 2026 | hlf q3 full year 2026 guidance reaffirmation`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 72.0/72 小时、1218 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"}
原文全文
展开原文 · 1,997 字
Wall Street slips at the open as oil prices surge on sharp U.S.-Iran escalation
LOS ANGELES - Herbalife Ltd. (NYSE:HLF) reaffirmed its third quarter and full-year 2026 financial guidance on Monday, maintaining the outlook it provided on August 5, 2026.
The health and wellness company continues to expect year-over-year net sales growth for both the third quarter and full year 2026 on a reported and constant currency basis, according to a press release statement. The company also reaffirmed its adjusted EBITDA guidance for both periods.
For the third quarter, Herbalife projects net sales growth of 0.5% to 4.5% on a reported basis and 1.5% to 5.5% on a constant currency basis compared to the prior year. Adjusted EBITDA is expected to range between $160 million and $180 million, with capital expenditures between $15 million and $25 million. In the third quarter of 2025, the company reported net sales of $1,273.7 million and adjusted EBITDA of $163.0 million.
For the full year 2026, the company expects net sales growth of 2.5% to 5.5% on both a reported and constant currency basis. Adjusted EBITDA is projected to range from $670 million to $690 million on a reported basis and $690 million to $710 million on a constant currency basis. Capital expenditures are expected between $50 million and $70 million. Full-year 2025 net sales were $5,037.5 million with adjusted EBITDA of $657.6 million.
"Our outlook for the remainder of the year remains firmly on track," said John DeSimone, Chief Financial Officer. "We remain confident in our ability to deliver a fifth consecutive quarter of year-over-year net sales growth and continued momentum across the remainder of 2026."
The company’s guidance assumptions, including foreign exchange rates based on average daily exchange rates for the first two weeks of July 2026, remain unchanged from those disclosed on August 5, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
LOS ANGELES - Herbalife Ltd. (NYSE:HLF) reaffirmed its third quarter and full-year 2026 financial guidance on Monday, maintaining the outlook it provided on August 5, 2026.
The health and wellness company continues to expect year-over-year net sales growth for both the third quarter and full year 2026 on a reported and constant currency basis, according to a press release statement. The company also reaffirmed its adjusted EBITDA guidance for both periods.
For the third quarter, Herbalife projects net sales growth of 0.5% to 4.5% on a reported basis and 1.5% to 5.5% on a constant currency basis compared to the prior year. Adjusted EBITDA is expected to range between $160 million and $180 million, with capital expenditures between $15 million and $25 million. In the third quarter of 2025, the company reported net sales of $1,273.7 million and adjusted EBITDA of $163.0 million.
For the full year 2026, the company expects net sales growth of 2.5% to 5.5% on both a reported and constant currency basis. Adjusted EBITDA is projected to range from $670 million to $690 million on a reported basis and $690 million to $710 million on a constant currency basis. Capital expenditures are expected between $50 million and $70 million. Full-year 2025 net sales were $5,037.5 million with adjusted EBITDA of $657.6 million.
"Our outlook for the remainder of the year remains firmly on track," said John DeSimone, Chief Financial Officer. "We remain confident in our ability to deliver a fifth consecutive quarter of year-over-year net sales growth and continued momentum across the remainder of 2026."
The company’s guidance assumptions, including foreign exchange rates based on average daily exchange rates for the first two weeks of July 2026, remain unchanged from those disclosed on August 5, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。